BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21205021)

  • 1. Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes.
    Kacerovsky M; Brehm A; Chmelik M; Schmid AI; Szendroedi J; Kacerovsky-Bielesz G; Nowotny P; Lettner A; Wolzt M; Jones JG; Roden M
    J Intern Med; 2011 Feb; 269(2):189-99. PubMed ID: 21205021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.
    Szendroedi J; Schmid AI; Chmelik M; Toth C; Brehm A; Krssak M; Nowotny P; Wolzt M; Waldhausl W; Roden M
    PLoS Med; 2007 May; 4(5):e154. PubMed ID: 17472434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.
    Petersen KF; Dufour S; Shulman GI
    PLoS Med; 2005 Sep; 2(9):e233. PubMed ID: 16089501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute elevation of plasma lipids does not affect ATP synthesis in human skeletal muscle.
    Brehm A; Krssák M; Schmid AI; Nowotny P; Waldhäusl W; Roden M
    Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E33-8. PubMed ID: 20442322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle phosphodiester content relates to body mass and glycemic control.
    Szendroedi J; Schmid AI; Chmelik M; Krssak M; Nowotny P; Prikoszovich T; Kautzky-Willer A; Wolzt M; Waldhäusl W; Roden M
    PLoS One; 2011; 6(7):e21846. PubMed ID: 21779337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle.
    Brehm A; Krssak M; Schmid AI; Nowotny P; Waldhäusl W; Roden M
    Diabetes; 2006 Jan; 55(1):136-40. PubMed ID: 16380486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.
    Schrauwen-Hinderling VB; Kooi ME; Hesselink MK; Jeneson JA; Backes WH; van Echteld CJ; van Engelshoven JM; Mensink M; Schrauwen P
    Diabetologia; 2007 Jan; 50(1):113-20. PubMed ID: 17093944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy.
    Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA
    Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
    Petersen KF; Dufour S; Befroy D; Garcia R; Shulman GI
    N Engl J Med; 2004 Feb; 350(7):664-71. PubMed ID: 14960743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise.
    Yokoyama H; Mori K; Emoto M; Araki T; Teramura M; Mochizuki K; Tashiro T; Motozuka K; Inoue Y; Nishizawa Y
    Diabetes Obes Metab; 2008 May; 10(5):400-7. PubMed ID: 18410564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.
    Bernroider E; Brehm A; Krssak M; Anderwald C; Trajanoski Z; Cline G; Shulman GI; Roden M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5559-65. PubMed ID: 15998784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.
    Schmid AI; Szendroedi J; Chmelik M; Krssák M; Moser E; Roden M
    Diabetes Care; 2011 Feb; 34(2):448-53. PubMed ID: 21216854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.
    Krssak M; Falk Petersen K; Dresner A; DiPietro L; Vogel SM; Rothman DL; Roden M; Shulman GI
    Diabetologia; 1999 Jan; 42(1):113-6. PubMed ID: 10027589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramyocellular lipid content in subjects with impaired fasting glucose after telmisartan treatment, a randomised cross-over trial.
    Kratochvílová S; Škoch A; Wohl P; Švehlíková E; Dezortová M; Hill M; Hájek M; Pelikánová T
    Magn Reson Imaging; 2016 Apr; 34(3):353-8. PubMed ID: 26523653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects.
    Abdul-Ghani MA; Matsuda M; DeFronzo RA
    Diabet Med; 2008 Nov; 25(11):1289-94. PubMed ID: 19046218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.
    Perseghin G; Lattuada G; De Cobelli F; Esposito A; Costantino F; Canu T; Scifo P; De Taddeo F; Maffi P; Secchi A; Del Maschio A; Luzi L
    Diabetologia; 2005 Dec; 48(12):2615-21. PubMed ID: 16261312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity.
    Meex RC; Schrauwen-Hinderling VB; Moonen-Kornips E; Schaart G; Mensink M; Phielix E; van de Weijer T; Sels JP; Schrauwen P; Hesselink MK
    Diabetes; 2010 Mar; 59(3):572-9. PubMed ID: 20028948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced skeletal muscle phosphocreatine concentration in type 2 diabetic patients: a quantitative image-based phosphorus-31 MR spectroscopy study.
    Ripley EM; Clarke GD; Hamidi V; Martinez RA; Settles FD; Solis C; Deng S; Abdul-Ghani M; Tripathy D; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E229-E239. PubMed ID: 29509433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone-induced improvements in insulin sensitivity occur without concomitant changes in muscle mitochondrial function.
    Bajpeyi S; Pasarica M; Conley KE; Newcomer BR; Jubrias SA; Gamboa C; Murray K; Sereda O; Sparks LM; Smith SR
    Metabolism; 2017 Apr; 69():24-32. PubMed ID: 28285649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.